Manatuck Hill Partners, LLC Icad Inc Transaction History

Manatuck Hill Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$3.92 - $7.48 $828,296 - $1.58 Million	-211,300 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$14.9 - $20.82 $558,750 - $780,750	-37,500 Reduced 15.07%	211,300 $3.66 Million
Q1 2021 May 14, 2021	BUY	$12.57 - $21.22 $471,375 - $795,750	37,500 Added 17.75%	248,800 $5.28 Million
Q4 2020 Feb 16, 2021	SELL	$8.73 - $14.56 $439,992 - $733,824	-50,400 Reduced 19.26%	211,300 $2.79 Million
Q3 2020 Nov 16, 2020	BUY	$8.56 - $11.6 $439,128 - $595,080	51,300 Added 24.38%	261,700 $2.31 Million
Q1 2020 May 15, 2020	BUY	$6.94 - $14.42 $904,976 - $1.88 Million	130,400 Added 163.0%	210,400 $1.54 Million
Q2 2019 Aug 14, 2019	BUY	$4.53 - $7.0 $362,400 - $560,000	80,000 New	80,000 $510,000

5.39M

3.6K

14.6K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $61.3M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Manatuck Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Manatuck Hill Partners, LLC with notifications on news.